----
Current ValuationThe current P/E ratio is 57.95, above the reasonable range, cheaper than 0.77% of the time in the past 5 years, and the industry ranks 40/172, the industry Median -0.92.
57.95xP/E
$200.42Stock price
$3.46Earnings per share
57.95xP/E
Stock price$200.42Earnings per share$3.46
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 42.97x
- Typical range
- 34.82x–49.57x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
015304560
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
ISRGUSIntuitive Surgical | 53.02x | 11.19% | $156.80B |
BDXUSBecton Dickinson and | 57.95x | 13.37% | $54.59B |
EWUSEdwards Lifesciences | 51.67x | 37.85% | $51.93B |
IRMDUSiRadimed | 48.61x | 10.67% | $1.12B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
